[{"uuid": "45bccb20-268d-3075-a01b-a9521d2dfc3a", "title": "BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bmy-gets-positive-chmp-opinion-183400618.html", "providerPublishTime": 1738607640, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SlGE5JR4xp73Vb5zTu29cQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iAjYTqhtpV3hPzryhmSe_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "9fcf51c2-2679-39d9-921f-768460c1ffa1", "title": "Bank of New York Mellon and Fox Show Value and Momentum", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/bank-york-mellon-fox-show-194614649.html", "providerPublishTime": 1738611974, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sukEayI5AhQyV8N0_oO..g--~B/aD01NDQ7dz04MTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f2ce61619bd225eee56d1ef49d4ac7fb", "width": 816, "height": 544, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/f0E4wrvKNxdgbmJPde8LEg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/f2ce61619bd225eee56d1ef49d4ac7fb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["FOXA", "^GSPC", "BK"]}, {"uuid": "f0fa96a7-96c8-3024-b3c9-b95edca86588", "title": "How Trump\u2019s Tariffs Could Impact the Housing Market", "publisher": "GOBankingRates", "link": "https://finance.yahoo.com/news/trump-tariffs-could-impact-housing-120156222.html", "providerPublishTime": 1738429215, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SHPma7meHvo_ULJOTem.Nw--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/gobankingrates_644/4ef6654fec1bd82535e70df271a62685", "width": 1920, "height": 1080, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/M.yyEjBtXLTCDHMp8XG_Ng--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/gobankingrates_644/4ef6654fec1bd82535e70df271a62685", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "a084f8ac-ac88-3197-bffd-a74568b5b89f", "title": "Is Warrior Met Coal Inc. (HCC) the Best Coal Stock to Invest In Right Now?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/warrior-met-coal-inc-hcc-084430805.html", "providerPublishTime": 1738313070, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.F.wGq0LQHCiLZVs_B2MZg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/36d378bdeb5a56751ad01c1fcc4846b2", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yI3XtYcEg6KWa_juO9GtNA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/36d378bdeb5a56751ad01c1fcc4846b2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HCC"]}, {"uuid": "31630965-cf1b-39a1-9c1d-ce0ced3c4044", "title": "Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo\u00ae (nivolumab) plus Yervoy\u00ae (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/bristol-myers-squibb-receives-positive-115900977.html", "providerPublishTime": 1738324740, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JRtyzBadqE1Nq.uHIWMUwQ--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9d41d7dd6df6bd90003c55184674f52d", "width": 1497, "height": 206, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WJy8uojPrXdfK6vNe_ylZw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9d41d7dd6df6bd90003c55184674f52d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BMY", "CELG-RT"]}, {"uuid": "55b79a48-7d43-3bb3-9f5b-59f63a1e08d9", "title": "Zacks Industry Outlook Highlights Peabody Energy, Warrior Met Coal, SunCoke Energy and Ramaco Resources", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/zacks-industry-outlook-highlights-peabody-102800909.html", "providerPublishTime": 1738319280, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nakDF28fwFPSC1sAZw9tVA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/65a36466021034eeade59ab3c7f6752e", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/aZNAH4kUV8F8mS0Om9_Ang--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/65a36466021034eeade59ab3c7f6752e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BTU", "METCZ", "SXC", "^GSPC", "HCC"]}, {"uuid": "7398ea6b-2220-3ad7-b9f6-e7aed041eb1c", "title": "Interventional Oncology Market to Hit USD 4.24 Billion by 2029 with 9.0% CAGR | MarketsandMarkets\u2122", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/interventional-oncology-market-hit-usd-153000520.html", "providerPublishTime": 1738337400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0wq0mqaC3uHfquplOT_Srg--~B/aD0xMzc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5a78c54862092389c9116d8d0e3d37f7", "width": 400, "height": 137, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1ofTELpr2RWCu15D5ShgSw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/5a78c54862092389c9116d8d0e3d37f7", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "38cf4887-85ef-3652-8b62-bbd08745d406", "title": "4 Coal Stocks to Watch Despite Ongoing Industry Weakness", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/4-coal-stocks-watch-despite-151500271.html", "providerPublishTime": 1738250100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nakDF28fwFPSC1sAZw9tVA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/65a36466021034eeade59ab3c7f6752e", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/aZNAH4kUV8F8mS0Om9_Ang--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/65a36466021034eeade59ab3c7f6752e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BTU", "^GSPC", "HCC", "METCZ", "SXC"]}, {"uuid": "1e9cc070-8348-3265-a02a-73940340d477", "title": "TMHCCI taps Optalitix to enhance London Market underwriting and pricing systems", "publisher": "Life Insurance International", "link": "https://finance.yahoo.com/m/1e9cc070-8348-3265-a02a-73940340d477/tmhcci-taps-optalitix-to.html", "providerPublishTime": 1738168492, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/3XZmLqV23LKj55IZs9hfqw--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/life_insurance_international_186/d3243ed8cff0e8819ae1bb7c4505a188", "width": 1440, "height": 810, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/SMQMPtADktSX4LBLHrp7Vg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/life_insurance_international_186/d3243ed8cff0e8819ae1bb7c4505a188", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "733ef18b-ce16-37a1-b228-47e5dfc3092d", "title": "Elevar Therapeutics Announces the Formation and Members of Scientific Advisory Board", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/elevar-therapeutics-announces-formation-members-173900660.html", "providerPublishTime": 1737999540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5oZHg8QF7VYsKgREjjId_Q--~B/aD0xMDYxO3c9MjA5NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/23e19a63007fa3984c6f2b429140b970", "width": 2097, "height": 1061, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WXlh8fVq7Atk3Fw7liDFlg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/23e19a63007fa3984c6f2b429140b970", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "2b6f0ed6-16df-32cd-9678-aed342887447", "title": "US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/us-patent-office-granted-fite-120000820.html", "providerPublishTime": 1737979200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sJtGBGhYav13.OX82J5L2A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6114327b6294df8bacb7f8b771866c2b", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/YoMiI75f_LEUIRg3WQR9Ww--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/6114327b6294df8bacb7f8b771866c2b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CANF"]}, {"uuid": "c668faae-6029-3b53-bc8d-7650169da1ad", "title": "Ascelia Pharma Announces Acceptance of Three Scientific Abstracts with SPARKLE Phase 3 Data at the European Society of Gastrointestinal and Abdominal Radiology Annual Meeting", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ascelia-pharma-announces-acceptance-three-070000590.html", "providerPublishTime": 1737961200, "type": "STORY", "relatedTickers": ["ACE-TO1.ST", "ACE.ST"]}, {"uuid": "553eaeae-ce7f-329e-8d2e-2d2dcc0df96f", "title": "Herr Memorial Library in Mifflinburg names new director", "publisher": "The Daily Item, Sunbury, Pa.", "link": "https://finance.yahoo.com/m/553eaeae-ce7f-329e-8d2e-2d2dcc0df96f/herr-memorial-library-in.html", "providerPublishTime": 1737829080, "type": "STORY"}, {"uuid": "ba9358e5-bbb2-3a0c-bc3e-781bc81d8da0", "title": "Henry Crown and Company Announces New Board and Leadership", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/henry-crown-company-announces-board-134500976.html", "providerPublishTime": 1737726300, "type": "STORY"}, {"uuid": "19804102-c1d0-3b94-9614-8df1ac453885", "title": "Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo\u00ae (nivolumab) plus Yervoy\u00ae (ipilimumab) Compared to Opdivo Monotherapy...", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/bristol-myers-squibb-presents-results-150200990.html", "providerPublishTime": 1737817320, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/4btKmuC97hKuA4unLHFN3w--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/b73c07d4aa97b00065f38219795161d2", "width": 1497, "height": 206, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/95NuvXyv2Fgb38M9pLGVPw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/b73c07d4aa97b00065f38219795161d2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BMY", "CELG-RT"]}, {"uuid": "5a90f711-9681-3bd0-b64e-a12a477077c6", "title": "Elevar Therapeutics Presents Results from Post-Hoc Analysis of CARES-310 Study Evaluating the Impact of Viral and Non-Viral Etiology on Survival in Hepatocellular Carcinoma", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/elevar-therapeutics-presents-results-post-154100805.html", "providerPublishTime": 1737733260, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5oZHg8QF7VYsKgREjjId_Q--~B/aD0xMDYxO3c9MjA5NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/23e19a63007fa3984c6f2b429140b970", "width": 2097, "height": 1061, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WXlh8fVq7Atk3Fw7liDFlg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/23e19a63007fa3984c6f2b429140b970", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "4fd10a7d-6de7-3f09-87f6-fdb8d4a47f28", "title": "Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Study Evaluating Cabozantinib in Advanced Gastrointestinal Neuroendocrine Tumors Presented at ASCO GI 2025", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/exelixis-announces-results-subgroup-analysis-193000830.html", "providerPublishTime": 1737747000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/WsymuGWG5aVqSmQNT2pRvQ--~B/aD0zMjc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/66f496e69027644d1d25c4c0f922d8f2", "width": 1200, "height": 327, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/DXAZGikX6koGVsUB1Z3BhQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/66f496e69027644d1d25c4c0f922d8f2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EXEL"]}, {"uuid": "72713afc-984c-3dd7-8496-33b46ddfe76e", "title": "Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA\u00ae (pembrolizumab) Plus LENVIMA\u00ae (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/merck-eisai-phase-3-leap-114500065.html", "providerPublishTime": 1737719100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/hay29cQLcET.MPtsFg3uCA--~B/aD0yMTc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/55d6886e700ef165127b6c2b5729bbb1", "width": 480, "height": 217, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/uvPuYw1W36v3dqZAAHwlyQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/55d6886e700ef165127b6c2b5729bbb1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MRK"]}, {"uuid": "8740cc7a-acfc-3327-8e99-c720b5de623c", "title": "Warrior Sets Date for Fourth Quarter 2024 Earnings Announcement and Investor Conference Call", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/warrior-sets-date-fourth-quarter-210500486.html", "providerPublishTime": 1737579900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/8jnj2UWwr_G.tsfD.hwVqw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/82361435bf4c91cd122da9480ee17132", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Reqez4wnnXZCPBxmC3n7bQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/82361435bf4c91cd122da9480ee17132", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HCC"]}, {"uuid": "6f59ce52-ed3e-3b14-9c17-e9ebe24c0546", "title": "Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/coherus-presents-final-phase-2-120000655.html", "providerPublishTime": 1737547200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/c44XrZdHt3bMpdwrfeLY5A--~B/aD0yNDQ7dz05ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2735b7c71f366d11799f3c657ae3c6a4", "width": 980, "height": 244, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/VaJZl1T8eKR3sWvYpw.hTQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2735b7c71f366d11799f3c657ae3c6a4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CHRS"]}]